Ben-Gurion University researchers develop innovative biosensor, team up with Israeli biotech company OncoHost in bid for FDA approval

Three-day annual conference, marking 20th year, brings together thousands of participants for newest innovations in medical and heath tech

Startup's blood test aims to predict which cancer patients will react better to treatment; 8 clinical trials will be set up in the UK

ONCOHOST, founded by the Technion's Yuval Shaked, is performing clinical trials; goal is to predict treatments' effectiveness and determine how to improve them, for each patient